FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Find answers to all your questions on live SEQUENT message board: Is SEQUENT buy or sell? Should I buy SEQUENT shares? Why are SEQUENT shares falling? Should I invest in SEQUENT stock?

forum

SEQUENT Share Price Discussion

Sequent Scientific Ltd.
NSE: SEQUENT | BSE: 512529 | ISIN: INE807F01027 | Sector: Pharmaceuticals and health care


Type
Buy
Instrument
SEQUENT
Entry Price
₹139
Price@Trade
₹139
Target Price
₹145
Stop Price
₹133.5
Valid Till
Aug 10, 2020 3:20 AM
Margin
₹139,000 approx for 1000 Qty
Status
Exited
Exit Price
₹143.25
Net P&L
+₹4,250 (+3.06%)
Like
Reply (1)
NSE:SEQUENT price when posted: 139
1 Replies

Update
Exited
Exit Price
₹143.25
Net P&L
+₹4,250 (+3.06%)
Recent posts in SEQUENT
R
Reputation: 1,566 • Sep 24 1:00 AM

BP Wealth target on SEQUENT
Date: 22-Sep-20 Broker: BP Wealth Price @ Call: 137.42 Target: 224 Potential: 0.63% Recommendation: BUY
1
Reply
W
Reputation: 6,968 • Sep 23 2:21 AM

Sequent Scientific has entered into a definitive agreement with promoter Dr.Huseyin Aydin for the acquisition of 40% stake from him in Provet for $17.1 million. Provet is amongst the top 3 and the largest local company in the veterinary medicines market in Turkey. - Pos...
Read more...
Like
Reply
T
Reputation: -4,785 • Sep 23 2:20 AM

Insider Trades

Surya Roshni: Promoters acquired 93,750 shares between September 17-21.

Sequent Scientific: Promoter Chayadeep Ventures sold 2.63 lakh shares between September 17-18.

IIFL Wealth Management: Promoter Karan Bhagat acquired 1 lakh shares on September 22.
#SURYA...
Read more...
Like
Reply
T
Reputation: 23,301 • Sep 15 5:44 AM
TradeAdda in SEQUENT
Sequent 148.50 From 140 bought yesterday with P...

Sequent
Made High 157 from 140 and 135.
#TradeAdda #SEQUENT
3
Reply (5)
A
Reputation: -582 • Sep 14 4:32 AM

Type
Buy
Instrument
SEQUENT
Entry Price
₹152
Price@Trade
₹152.1
Target Price
₹158
Stop Price
₹146
Valid Till
Sep 15, 2020 3:20 AM
Margin
₹152,000 approx for 1000 Qty
Status
Validity Over
Exit Price
₹153.2
Net P&L
+₹1,200 (+0.79%)
Like
Reply (2)
N
Reputation: 6,224 • Sep 11 2:21 AM
CCI approves Piramal Pharma and Carlyle Group deal
The transfer of equity will take place through the Groups special purpose vehicle Curie, a notice of the combination by the regulator said.
The Economic Times
Like
Reply